Vital KSK Holdings, Inc. (3151.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In JPY
Sector
Healthcare
Industry
Medical - Distribution
Employees
3705
First IPO Date
January 01, 2001
| Name | Title | Pay | Year Born |
| Taisuke Murai | Chief Executive Officer, President & Representative Director | 0 | 1954 |
| Yuichi Kobayashi | Executive Officer & Manager of Business Devel. Depar. and Represen. Director of Med. Pharma Co., Ltd | 0 | N/A |
| Akira Teramura | Executive Officer and GM of Sales & Purchase Division | 0 | N/A |
| Hideo Takeda | Executive Officer and GM of Legal & Compliance Department | 0 | N/A |
| Hiroshi Hiratani | Executive Officer & In Charge of SCM & GM of GDP Management Dept. | 0 | N/A |
| Hiroshi Yokoyama | Executive Officer, Head of Corporate Plannning Office & Corporate Planning Department | 0 | N/A |
| Isao Kita | Director of Accounting & Finance and Director | 0 | 1966 |
| Kenta Sato | Executive Officer, Manager of Corporation Planning Department & Head of Corporate Communications Office | 0 | N/A |
| Junshi Iguchi | Executive Vice President & Director | 0 | 1968 |
| Takeshi Ichijo | Executive Vice President & Representative Director | 0 | 1959 |
| Shigemi Naito | Executive Officer & GM of General Affairs & Human Resources Department | 0 | N/A |
Vital KSK Holdings, Inc. is a Japanese entity primarily involved in the wholesale distribution of pharmaceutical products. Its diverse wholesale operations also cover veterinary medications, agricultural chemicals and supplies, and various types of medical and nursing care equipment. Beyond its core distribution activities, the company manages a range of services including operating pharmacies, providing nursing care, transportation, insurance agency services, real estate management, and parking facilities. It also runs a mail-order business focused on health-related products and offers pharmacy dispensing services. Furthermore, Vital KSK Holdings provides medical management consulting and manufactures over-the-counter (OTC) drugs. The company was established in 2009 and maintains its headquarters in Tokyo, Japan.